TR199800046A2 - Aktif maddeler yaratilmasi için nükleik asit olusumu. - Google Patents
Aktif maddeler yaratilmasi için nükleik asit olusumu.Info
- Publication number
- TR199800046A2 TR199800046A2 TR1998/00046A TR9800046A TR199800046A2 TR 199800046 A2 TR199800046 A2 TR 199800046A2 TR 1998/00046 A TR1998/00046 A TR 1998/00046A TR 9800046 A TR9800046 A TR 9800046A TR 199800046 A2 TR199800046 A2 TR 199800046A2
- Authority
- TR
- Turkey
- Prior art keywords
- nucleic acid
- formation
- active substances
- create active
- create
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Bulus, memeli hücrelerinden alinan bir enzim tarafindan aktif hale getirilen bir aktif madde yaratmaya yönelik bir nükleik asit olusumuyla ve nükleik asit olusumunun, hastaliklari tedavi etmeye yönelik bir ilacin hazirlanmasinda kullanimiyla ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19701141A DE19701141C1 (de) | 1997-01-16 | 1997-01-16 | Genkonstrukte für durch Proteasen aktivierbare Wirksubstanzen |
Publications (2)
Publication Number | Publication Date |
---|---|
TR199800046A3 TR199800046A3 (tr) | 1998-10-21 |
TR199800046A2 true TR199800046A2 (tr) | 1998-10-21 |
Family
ID=7817422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1998/00046A TR199800046A2 (tr) | 1997-01-16 | 1998-01-14 | Aktif maddeler yaratilmasi için nükleik asit olusumu. |
Country Status (15)
Country | Link |
---|---|
US (3) | US6080575A (tr) |
EP (1) | EP0859058A3 (tr) |
JP (1) | JPH10210973A (tr) |
KR (1) | KR19980070549A (tr) |
CN (1) | CN1192473A (tr) |
AR (1) | AR008555A1 (tr) |
AU (1) | AU738717B2 (tr) |
BR (1) | BR9800341A (tr) |
CA (1) | CA2227159A1 (tr) |
CZ (1) | CZ13298A3 (tr) |
DE (1) | DE19701141C1 (tr) |
HU (1) | HUP9800075A3 (tr) |
PL (1) | PL324328A1 (tr) |
RU (1) | RU2204414C2 (tr) |
TR (1) | TR199800046A2 (tr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10039844A1 (de) * | 1999-08-10 | 2001-04-19 | Hepavec Ag Fuer Gentherapie | Kombinationsvektoren für den Gentransfer, Verfahren zu ihrer Herstellung und ihre Verwendung |
EP1283719B1 (de) * | 2000-04-22 | 2007-09-05 | PharmedArtis GmbH | Apoptotika |
WO2002020715A2 (en) * | 2000-09-05 | 2002-03-14 | Biosight Ltd. | Peptide conjugated anti-cancer prodrugs |
US8314060B2 (en) | 2000-09-05 | 2012-11-20 | Biosight Ltd. | Peptide conjugated anti-cancer prodrugs |
US7273722B2 (en) * | 2000-11-29 | 2007-09-25 | Allergan, Inc. | Neurotoxins with enhanced target specificity |
US7041787B2 (en) * | 2000-12-29 | 2006-05-09 | Kimberly-Clark Worldwide, Inc. | Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
US6600057B2 (en) | 2000-12-29 | 2003-07-29 | Kimberly-Clark Worldwide, Inc. | Matrix metalloproteinase inhibitors |
US7141392B2 (en) * | 2001-01-09 | 2006-11-28 | Queen Mary And Westfield College | Latent fusion protein |
US6942853B2 (en) * | 2001-01-09 | 2005-09-13 | Queen Mary And Westfield College | Latent fusion protein |
GB0105929D0 (en) * | 2001-03-09 | 2001-04-25 | Btg Int Ltd | Physiologically activated prodrugs |
EP1385994A2 (de) * | 2001-04-02 | 2004-02-04 | Bayer HealthCare AG | Verfahren zur spezifischen detektion, isolation und charakterisierung von zellen aus körperproben durch transfektion von nukleinsäurekonstrukten |
US7247618B2 (en) | 2001-04-30 | 2007-07-24 | Tripathi Rajavashisth | Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
US20030157641A1 (en) * | 2001-11-16 | 2003-08-21 | Idec Pharmaceuticals Corporation | Polycistronic expression of antibodies |
WO2003051393A2 (en) * | 2001-12-17 | 2003-06-26 | University Of Wales College Of Medicine | Enzymatic cleavable reagents for specific delivery to disease sites |
US20030119073A1 (en) * | 2001-12-21 | 2003-06-26 | Stephen Quirk | Sensors and methods of detection for proteinase enzymes |
AU2003217415B2 (en) * | 2002-02-14 | 2009-01-08 | William J Rutter | Chimeric molecules for cleavage in a treated host |
CN1780920B (zh) * | 2003-05-12 | 2012-03-28 | 波多玛克制药有限公司 | 基因表达抑制剂 |
EP1639097B1 (en) * | 2003-06-25 | 2013-08-07 | Ottawa Health Research Institute | Methods and compositions for modulating stem cell growth and differentiation |
US20060153797A1 (en) * | 2004-06-11 | 2006-07-13 | Bortolotto Susan K | Tissue material and matrix |
KR100604976B1 (ko) * | 2004-09-03 | 2006-07-28 | 학교법인연세대학교 | 다작용기 리간드로 안정화된 수용성 나노입자 |
WO2008013918A2 (en) * | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
BRPI0721630A2 (pt) | 2007-05-02 | 2013-10-15 | Merial Ltd | Plasmídeo de dna tendo expressão e estabilidade aperfeiçoadas |
WO2008156789A2 (en) * | 2007-06-15 | 2008-12-24 | The Scripps Research Institute | Methods and compositions for identifying binding partners from libraries of biomolecules |
GB0800272D0 (en) * | 2008-01-08 | 2008-02-13 | Plant Bioscience Ltd | Protein expression systems |
EP3543256A1 (en) | 2009-01-12 | 2019-09-25 | Cytomx Therapeutics Inc. | Modified antibody compositions, methods of making and using thereof |
WO2011123683A2 (en) * | 2010-04-02 | 2011-10-06 | University Of Rochester | Protease activated cytokines |
EP2628748A1 (en) | 2012-02-14 | 2013-08-21 | Szilak Laboratories Bioinformatics & Molecule-Design Ltd. | Angiostatin chimeras and uses thereof |
WO2014018120A1 (en) | 2012-07-25 | 2014-01-30 | Catalyst Biosciences, Inc. | Modified factor x polypeptides and uses thereof |
MA40094B1 (fr) * | 2014-08-06 | 2022-05-31 | Univ Miami | Protéines de fusion de l'interleukine-2/récepteur alpha de l'interleukine-2 et procédés d'utilisation |
AU2019271148B2 (en) | 2018-05-14 | 2023-07-06 | Werewolf Therapeutics, Inc. | Activatable interleukin-2 polypeptides and methods of use thereof |
MX2020012252A (es) | 2018-05-14 | 2021-04-28 | Werewolf Therapeutics Inc | Polipeptidos de interleucina 12 activables y metodos de uso de los mismos. |
CA3137512A1 (en) | 2019-05-14 | 2020-11-19 | Werewolf Therapeutics, Inc. | Separation moieties and methods and use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4228457A1 (de) * | 1992-08-27 | 1994-04-28 | Beiersdorf Ag | Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen |
GB9506466D0 (en) | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
SE9403613D0 (sv) | 1994-10-21 | 1994-10-21 | Pharmacia Ab | Improvement of an expression vector for production of recombinant proteins |
AU4608296A (en) * | 1994-12-30 | 1996-07-31 | Chiron Corporation | Methods and compositions for treatment of solid tumors in vivo |
US5726050A (en) | 1995-06-20 | 1998-03-10 | Massachusetts Institute Of Technology | Z-DNA binding protein and applications |
JPH11509088A (ja) | 1995-06-23 | 1999-08-17 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 血管内皮増殖因子受容体をコードする遺伝子の転写調節 |
DE19605274A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Nukleinsäurekonstrukte für die zellzyklusregulierte Expression von Genen, derartige Konstrukte enthaltende Zellen sowie deren Verwendung zur Herstellung von Heilmitteln |
DE19605279A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung |
EP0941334B1 (en) * | 1996-11-06 | 2004-06-02 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Protease-activatable pseudomonas exotoxin a-like proproteins |
-
1997
- 1997-01-16 DE DE19701141A patent/DE19701141C1/de not_active Expired - Fee Related
-
1998
- 1998-01-14 CZ CZ98132A patent/CZ13298A3/cs unknown
- 1998-01-14 TR TR1998/00046A patent/TR199800046A2/tr unknown
- 1998-01-14 AR ARP980100164A patent/AR008555A1/es unknown
- 1998-01-14 CN CN98103791A patent/CN1192473A/zh active Pending
- 1998-01-15 EP EP98100632A patent/EP0859058A3/de not_active Withdrawn
- 1998-01-15 RU RU98100678/14A patent/RU2204414C2/ru not_active IP Right Cessation
- 1998-01-15 HU HU9800075A patent/HUP9800075A3/hu unknown
- 1998-01-16 US US09/008,308 patent/US6080575A/en not_active Expired - Lifetime
- 1998-01-16 KR KR1019980001096A patent/KR19980070549A/ko not_active Application Discontinuation
- 1998-01-16 BR BR9800341A patent/BR9800341A/pt not_active IP Right Cessation
- 1998-01-16 AU AU52107/98A patent/AU738717B2/en not_active Ceased
- 1998-01-16 PL PL98324328A patent/PL324328A1/xx unknown
- 1998-01-16 JP JP10006589A patent/JPH10210973A/ja active Pending
- 1998-01-16 CA CA002227159A patent/CA2227159A1/en not_active Abandoned
-
1999
- 1999-02-24 US US09/256,237 patent/US6670147B1/en not_active Expired - Lifetime
-
2003
- 2003-08-12 US US10/638,537 patent/US20040110682A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TR199800046A3 (tr) | 1998-10-21 |
PL324328A1 (en) | 1998-07-20 |
HUP9800075A3 (en) | 2004-03-29 |
KR19980070549A (ko) | 1998-10-26 |
CN1192473A (zh) | 1998-09-09 |
DE19701141C1 (de) | 1998-04-09 |
US20040110682A1 (en) | 2004-06-10 |
CZ13298A3 (cs) | 1998-08-12 |
EP0859058A2 (de) | 1998-08-19 |
EP0859058A3 (de) | 2003-05-28 |
JPH10210973A (ja) | 1998-08-11 |
AR008555A1 (es) | 2000-01-19 |
US6080575A (en) | 2000-06-27 |
HUP9800075A2 (hu) | 1998-10-28 |
RU2204414C2 (ru) | 2003-05-20 |
CA2227159A1 (en) | 1998-07-16 |
US6670147B1 (en) | 2003-12-30 |
BR9800341A (pt) | 1999-06-29 |
AU738717B2 (en) | 2001-09-27 |
AU5210798A (en) | 1998-07-23 |
HU9800075D0 (en) | 1998-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199800046A2 (tr) | Aktif maddeler yaratilmasi için nükleik asit olusumu. | |
NO993709D0 (no) | Stabilisert blanding omfattende fibrinogen | |
FR2714830B1 (fr) | Composition contenant des acides nucléiques, préparation et utilisations. | |
TR199902484T2 (tr) | Biyolojik yönden aktif maddeler ihtiva eden yapisici mikrokapsüller | |
TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
CY1105154T1 (el) | Ενσωματωση δραστικων ουσιων σε μητρες ουσιων-φορεων | |
FR2715847B1 (fr) | Composition contenant des acides nucléiques, préparation et utilisations. | |
TR199902730T2 (tr) | Glikrizikasit ve antiviral etkinlik kazandirilmis en azindan bir proteini içeren farmasötik antiviral bilesim. | |
TR200101970T2 (tr) | Solunum yollarì hastalìklarìnìn tedavisinde matriks metaloproteaz inhibitrleri olarak ikameli 4-biarilbutirik ve 5-biarilpentanoik asit trevlerinin kullanìlmasì | |
DE69809561T2 (de) | Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod | |
DE69528170T2 (de) | Intrazelluläre verabreichung therapeutischer sustanzenmittels virosomen | |
ES2158094T3 (es) | Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina. | |
SE9803272D0 (sv) | A drug for cell regeneration | |
TR199901987T2 (tr) | Suda çözünmezligi yüksek bir etken madde ihtiva eden sulu farmakolojik bilesim. | |
ATE326520T1 (de) | Teilchen für flüssige zubereitungen | |
ES2170845T3 (es) | Procedimiento para la inactivacion de virus en proteinas. | |
ATE302264T1 (de) | Freigabe von intrazellulärem material | |
NO20003888L (no) | Anti-enzympreparater omfattende etylendiamindiravsyre | |
DE60225587D1 (de) | Protease assay zur kontrolle medikamentöser therapie | |
DE60036929D1 (de) | Gentherapeutika | |
DK0758342T3 (da) | Hidtil ukendt peptidisk aktivt stof og fremstilling heraf | |
DE69814856D1 (de) | Wirkstoffe zur erzeugung von vorzug und annahme | |
TR199900748A2 (tr) | Osteinduktif protein ve dorsalize faktörünün kombinasyonunun kullanilmasi. | |
PT1380208E (pt) | Agente desinfectante com actividade antiparasitica | |
NO980175L (no) | Anvendelse av kationiske biopolymerer for å fremstille antiflassmidler |